![Pierre BLANCHARD | Medical Doctor | MD (radiation oncology) PhD (biostatistics - public health) | Institut de Cancérologie Gustave Roussy, Villejuif | IGR | Department of Radiotherapy | Research profile Pierre BLANCHARD | Medical Doctor | MD (radiation oncology) PhD (biostatistics - public health) | Institut de Cancérologie Gustave Roussy, Villejuif | IGR | Department of Radiotherapy | Research profile](https://i1.rgstatic.net/ii/profile.image/1148766291791873-1650898635375_Q512/Pierre-Blanchard.jpg)
Pierre BLANCHARD | Medical Doctor | MD (radiation oncology) PhD (biostatistics - public health) | Institut de Cancérologie Gustave Roussy, Villejuif | IGR | Department of Radiotherapy | Research profile
![Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile](https://i1.rgstatic.net/ii/profile.image/669948452036624-1536739566326_Q512/Jean-Pierre-Pouget-2.jpg)
Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile
![SSR126768A: a new selective and orally-active oxytocin receptor antagonist for the prevention of preterm labor | Journal of Pharmacology and Experimental Therapeutics SSR126768A: a new selective and orally-active oxytocin receptor antagonist for the prevention of preterm labor | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/early/2004/01/13/jpet.103.061200.extract.jpg)